# Mayewell Capital

Mayewell Capital is an Asset Manager based in Bryn Mawr, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Bryn Mawr, United States
- **Region:** North America
- **Address:** Bryn Mawr, PA, United States
- **Assets under management:** Undisclosed
- **Website:** mayewellcapital.com

## Regulatory record

- **Reports private funds:** No

## About

Mayewell Capital is an investment firm focused on healthcare, pharmaceuticals, and biotechnology. It has made two investments, including a Bridge investment in ThirtyFiveBio on April 15, 2025.

## Sectors

- Healthcare Services

## People

- John Zhu — Founder, President, CIO, and Managing Member

## Questions

### Who runs investment decisions at Mayewell Capital?

John Zhu, the firm's Founder, President, CIO, and Managing Member, runs investment decisions. He is the sole named investment principal in firm communications. W. Wong is listed as a business partner through official corporate channels, though no specific investment role has been disclosed publicly.

### How is Mayewell Capital related to Ingenio Therapeutics?

John Zhu serves simultaneously as CEO and Founder of Ingenio Therapeutics, a separate operating company, while managing Mayewell Capital. The relationship is not formally structured as a family office or captive venture arm — the two entities share a common founder but operate under distinct corporate identities. This dual role gives Mayewell a diligence mechanism rooted in operating experience within the therapeutics sector.

## Related profiles

- [Maycomb Capital](https://altss.com/profile/maycomb-capital)
- [Mayfair 101](https://altss.com/profile/mayfair-101)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/mayewell-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology